CPT code 15833 represents the surgical removal of excessive skin and subcutaneous tissue of the leg. This procedure addresses functional impairment, mobility limitations, or contour deformities caused by redundant tissue and is performed by dermatologic or plastic surgery specialists in ambulatory surgical centers or hospital surgical settings. Nationally, it matters because it intersects medical necessity determinations, coverage policy for reconstructive versus cosmetic intent, and site-of-service considerations that influence payment and access.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common billing and coding considerations, and what to expect in payer coverage approaches. The publication summarizes benchmark payment patterns, typical places of service, and policy language that commonly informs coverage decisions for removal of excess skin and subcutaneous tissue of the leg.

The report is useful for clinicians, billing professionals, and policy analysts seeking a national perspective on coding, service definitions, and payer alignment for this surgical procedure. Data not available in the input is noted where applicable.